This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of lymphoma subtypes. Lymphoma includes: Expert contributors from across the US and Canada Multidisciplinary coverage and emphasis on emerging therapeutic options, cutting edge developments and clinical research with near-term potential in clinical management Series Description: Emerging Cancer Therapeutics is an invited review publication providing a thorough analysis of key clinical research related to cancer therapeutics, including a discussion and assessment of current evidence; current clinical best practice, and likely near future developments. There is an emphasis throughout on multidisciplinary approaches to the specialty, as well as on quality and outcomes analysis. Published three times a year, Emerging Cancer Therapeutics provides authoritative, thorough assessments of advances in therapeutics in all major areas of oncology, both solid and hematologic malignancies, with a focus on advances in medical and biological therapies with emerging clinical impact and encompassing new technologies with implications for management such as molecular imaging.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Arnab Chakravarti, MD, Chair and Professor, Department of Radiation Oncology Max Morehouse Chair of Cancer Research, Co-Director, Brain Tumour Program, Arthur G. James Comprehensive Cancer Centre and Richard L. Solove Research Institute, The Ohio State University Medical School Martin Fuss, MD, Professor and Vice Chair, Director Program in Image-guided Radiation Therapy, Department of Radiation Medicine, Oregon Health & Science University Charles R. Thomas, MD, Professor and Chairman, Department of Radiation Medicine, Oregon Health and Science University
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: suffolkbooks, Center moriches, NY, USA
hardcover. Zustand: Very Good. Fast Shipping - Safe and Secure 7 days a week! Bestandsnummer des Verkäufers 3TWDDA003NHW
Anzahl: 3 verfügbar
Anbieter: BOOKWEST, Phoenix, AZ, USA
Hardcover. Zustand: New. 1st Edition. SHRINK-WRAPPED: US SELLER SHIPS FROM USA. Bestandsnummer des Verkäufers ORD7-S0-HC-1936287781-2P3-B6-MC-2012
Anzahl: 1 verfügbar
Anbieter: Hay-on-Wye Booksellers, Hay-on-Wye, HEREF, Vereinigtes Königreich
Zustand: As New. Bestandsnummer des Verkäufers 096487-1
Anzahl: 1 verfügbar
Anbieter: Basi6 International, Irving, TX, USA
Zustand: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Bestandsnummer des Verkäufers ABEOCT25-230369
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Bestandsnummer des Verkäufers ABBB-51700
Anbieter: SMASS Sellers, IRVING, TX, USA
Zustand: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed. Bestandsnummer des Verkäufers SNTA-51700
Anbieter: Books Puddle, New York, NY, USA
Zustand: New. pp. 208. Bestandsnummer des Verkäufers 2642980168
Anzahl: 1 verfügbar
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. pp. 208. Bestandsnummer des Verkäufers 49835159
Anzahl: 1 verfügbar
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Hardcover. Zustand: Brand New. 1st edition. 144 pages. 10.00x7.25x0.50 inches. In Stock. Bestandsnummer des Verkäufers zk1936287781
Anzahl: 1 verfügbar
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Hardcover. Zustand: new. Hardcover. This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of lymphoma subtypes. Lymphoma includes: Details the most current management across the spectrum of lymphoma subtypes Expert contributors from across the US and Canada Multidisciplinary coverage and emphasis on emerging therapeutic options, cutting edge developments and clinical research with near-term potential in clinical management Series Description: Emerging Cancer Therapeutics is an invited review publication providing a thorough analysis of key clinical research related to cancer therapeutics, including a discussion and assessment of current evidence; current clinical best practice, and likely near future developments. There is an emphasis throughout on multidisciplinary approaches to the speciality, as well as on quality and outcomes analysis. Published three times a year, Emerging Cancer Therapeutics provides authoritative, thorough assessments of advances in therapeutics in all major areas of oncology, both solid and haematologic malignancies, with a focus on advances in medical and biological therapies with emerging clinical impact and encompassing new technologies with implications for management such as molecular imaging. This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of lymphoma subtypes. It includes details the most current management across the spectrum of lymphoma subtypes; expert contributors from across the US and Canada; and multidisciplinary coverage and emphasis on emerging therapeutic options, cutting edge developments and clinical. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Bestandsnummer des Verkäufers 9781936287789